674 related articles for article (PubMed ID: 31513887)
1. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4
Wan Q; Liu Z; Yang M; Wu J
Toxicol Lett; 2019 Nov; 316():27-34. PubMed ID: 31513887
[TBL] [Abstract][Full Text] [Related]
2. The alternation of autophagy/apoptosis in CD4+CD25+Foxp3+ Tregs on the developmental stages of atherosclerosis.
Tian Y; Liang X; Wu Y
Biomed Pharmacother; 2018 Jan; 97():1053-1060. PubMed ID: 29136784
[TBL] [Abstract][Full Text] [Related]
3. Changes in CD4
Xue-Mei L; Jie C; Xuan D; Xiao-Xing L; Chun-Lin H; Yu-Jie L
Exp Biol Med (Maywood); 2017 May; 242(9):918-925. PubMed ID: 28114815
[TBL] [Abstract][Full Text] [Related]
4. Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice.
Chen T; Jia G; Wei Y; Li J
Toxicol Lett; 2013 Nov; 223(2):146-53. PubMed ID: 24045146
[TBL] [Abstract][Full Text] [Related]
5. Ambient fine particulate matter aggravates atherosclerosis in apolipoprotein E knockout mice by iron overload via the hepcidin-ferroportin axis.
Wan Q; Yang M; Liu Z; Wu J
Life Sci; 2021 Jan; 264():118715. PubMed ID: 33160991
[TBL] [Abstract][Full Text] [Related]
6. Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis.
Mor A; Planer D; Luboshits G; Afek A; Metzger S; Chajek-Shaul T; Keren G; George J
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):893-900. PubMed ID: 17272749
[TBL] [Abstract][Full Text] [Related]
7. Buyang Huanwu Decoction ameliorates atherosclerosis by regulating TGF-β/Smad2 pathway to promote the differentiation of regulatory T cells.
Chen S; Wang Y; Liang C; Li J; Li Y; Wu Q; Liu Z; Pang X; Chang YX
J Ethnopharmacol; 2021 Apr; 269():113724. PubMed ID: 33359003
[TBL] [Abstract][Full Text] [Related]
8. Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.
Huang K; Li SQ; Wang WJ; Liu LS; Jiang YG; Feng PN; Wang YQ; Wang SM
Int J Immunopathol Pharmacol; 2012; 25(2):397-406. PubMed ID: 22697071
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression.
Sharma M; Schlegel MP; Afonso MS; Brown EJ; Rahman K; Weinstock A; Sansbury BE; Corr EM; van Solingen C; Koelwyn GJ; Shanley LC; Beckett L; Peled D; Lafaille JJ; Spite M; Loke P; Fisher EA; Moore KJ
Circ Res; 2020 Jul; 127(3):335-353. PubMed ID: 32336197
[TBL] [Abstract][Full Text] [Related]
10. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells alleviate atherosclerosis by elevating number and function of CD4(+)CD25 (+)FOXP3 (+) regulatory T-cells and inhibiting macrophage foam cell formation.
Wang ZX; Wang CQ; Li XY; Feng GK; Zhu HL; Ding Y; Jiang XJ
Mol Cell Biochem; 2015 Feb; 400(1-2):163-72. PubMed ID: 25389006
[TBL] [Abstract][Full Text] [Related]
12. CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice.
Zhong Y; Wang X; Ji Q; Mao X; Tang H; Yi G; Meng K; Yang X; Zeng Q
J Clin Immunol; 2012 Oct; 32(5):1104-17. PubMed ID: 22552859
[TBL] [Abstract][Full Text] [Related]
13. FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
Lü CX; Xu RD; Cao M; Wang G; Yan FQ; Shang SS; Wu XF; Ruan L; Quan XQ; Zhang CT
Atherosclerosis; 2013 Jul; 229(1):263-70. PubMed ID: 23735638
[TBL] [Abstract][Full Text] [Related]
14. Air pollution is associated with the development of atherosclerosis via the cooperation of CD36 and NLRP3 inflammasome in ApoE
Du X; Jiang S; Zeng X; Zhang J; Pan K; Zhou J; Xie Y; Kan H; Song W; Sun Q; Zhao J
Toxicol Lett; 2018 Jun; 290():123-132. PubMed ID: 29571893
[TBL] [Abstract][Full Text] [Related]
15. B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.
Rattik S; Mantani PT; Yao Mattisson I; Ljungcrantz I; Sundius L; Björkbacka H; Terrinoni M; Lebens M; Holmgren J; Nilsson J; Wigren M; Nordin Fredrikson G
Vascul Pharmacol; 2018 Dec; 111():54-61. PubMed ID: 30243560
[TBL] [Abstract][Full Text] [Related]
16. Regulatory CD4
Kimura T; Kobiyama K; Winkels H; Tse K; Miller J; Vassallo M; Wolf D; Ryden C; Orecchioni M; Dileepan T; Jenkins MK; James EA; Kwok WW; Hanna DB; Kaplan RC; Strickler HD; Durkin HG; Kassaye SG; Karim R; Tien PC; Landay AL; Gange SJ; Sidney J; Sette A; Ley K
Circulation; 2018 Sep; 138(11):1130-1143. PubMed ID: 29588316
[TBL] [Abstract][Full Text] [Related]
17. Effect of Si-Miao-Yong-An decoction on the differentiation of monocytes, macrophages, and regulatory T cells in ApoE
Chen XN; Ge QH; Zhao YX; Guo XC; Zhang JP
J Ethnopharmacol; 2021 Aug; 276():114178. PubMed ID: 33945857
[TBL] [Abstract][Full Text] [Related]
18. Constitutive GITR Activation Reduces Atherosclerosis by Promoting Regulatory CD4+ T-Cell Responses-Brief Report.
Meiler S; Smeets E; Winkels H; Shami A; Pascutti MF; Nolte MA; Beckers L; Weber C; Gerdes N; Lutgens E
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1748-52. PubMed ID: 27444204
[TBL] [Abstract][Full Text] [Related]
19. Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1.
Chen WJ; Hu XF; Yan M; Zhang WY; Mao XB; Shu YW
Atherosclerosis; 2016 Jan; 244():108-12. PubMed ID: 26615520
[TBL] [Abstract][Full Text] [Related]
20. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
